852 results on '"Bachelez H"'
Search Results
2. Tofacitinib efficacy, patient‐reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.
3. 1616 Cross-comparison of inflammatory skin disease transcriptomics identifies PTEN as a pathogenic disease classifier in cutaneous lupus erythematosus
4. Quoi de neuf en thérapeutique dermatologique ?
5. 334 Invalidation of ADAR1 in human keratinocytes unravels its contribution to epithelial cell death and immunity
6. 104 The effect of present or historical psoriasis on the efficacy of spesolimab in patients with a generalized pustular psoriasis (GPP) flare
7. 117 Longitudinal follow-up study of arterial structure in patients with severe psoriasis and treated with ustekinumab or with tumor necrosis factor alpha inhibitors
8. 094 Characterisation of the immunogenicity of spesolimab in patients with a generalized pustular psoriasis (GPP) flare
9. Switchs de biothérapies chez les patients atteints de psoriasis modéré à sévère dans la cohorte française Psobioteq
10. Tanorexie et psoriasis sévère
11. Impact de la voie d’administration du méthotrexate sur son maintien en monothérapie dans le psoriasis cutané : données issues de la cohorte PSOBIOTEQ
12. Concentration sérique d’infliximab et réponse clinique au traitement dans l’hidradénite suppurée : étude rétrospective monocentrique de 22 cas
13. Facteurs prédictifs d’une poussée de psoriasis après une infection par le SARS-CoV-2 chez l’enfant
14. COVID-19 et psoriasis de l’enfant : facteurs associés à une évolution défavorable de la COVID-19 et impact de l’infection sur le psoriasis. Registre Chi-PsoCov
15. Infliximab treatment before and after surgery in severe hidradenitis suppurativa: A retrospective study of 10 patients
16. 291 Improvements in GPPGA score in patients experiencing a generalized pustular psoriasis (GPP) flare: Effisayil 1 study results
17. 479 Distinct patterns of gene expression in skin biopsies differentiate generalized pustular psoriasis (GPP) from psoriasis vulgaris (PV)
18. Image Gallery: Lenalidomide for the treatment of pseudotumoral herpes simplex virus type 2 infection in human immunodeficiency virus infection
19. Factors associated with the choice of the first biologic in psoriasis: real‐life analysis from the Psobioteq cohort
20. The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
21. POS1023 LONG-TERM SAFETY OF RISANKIZUMAB IN PATIENTS WITH PSORIATIC DISEASE: FINDINGS FROM INTEGRATED ANALYSES OF 17 CLINICAL TRIALS IN PSORIASIS AND 4 IN PSORIATIC ARTHRITIS
22. Predictors of long‐term drug survival for infliximab in psoriasis
23. Psoriasis pustuleux
24. Vaccine hesitancy and access to psoriasis care in the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
25. Détection précoce du rhumatisme psoriasique : quels outils en pratique ?
26. Les recommandations européennes et anglaises sur la place des biothérapies dans le psoriasis modéré à sévère
27. Infliximab
28. Choix thérapeutique en fonction du contexte clinique
29. Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*
30. Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013
31. Switches between biologics in patients with moderate‐to‐severe psoriasis: results from the French cohortPSOBIOTEQ.
32. European S3-Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC
33. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey
34. Out‐of‐pocket expenditures in France to manage psoriasis in adult patients: results from an observational, cross‐sectional, non‐comparative, multicentre study
35. Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort
36. Survenue de cancers cutanés chez les patients atteints de psoriasis exposés aux traitements conventionnels, à la photothérapie ou à une biothérapie : analyse d’une cohorte prospective de patients psoriasiques recevant des traitements systémiques
37. Les éruptions psoriasiformes sous dupilumab dans la dermatite atopique ont une signature transcriptomique proche du psoriasis pustuleux
38. Facteurs associés à l’absence de réponse à plusieurs lignes de biothérapies dans le psoriasis
39. Évolution temporelle de la prise en charge médicamenteuse des personnes âgées atteintes de psoriasis modéré à sévère : données d’une cohorte nationale académique
40. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study
41. Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians
42. The Uncertain Status of Cutaneous Pseudolymphoma
43. Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.
44. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
45. Partial clinical response to anakinra in severe palmoplantar pustular psoriasis
46. Psoriasis associated with idiopathic CD4+ T-cell lymphopenia: a regulatory T-cell defect?
47. Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?
48. Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas
49. Infliximab : Rémicade ®
50. High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.